Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2369368Generated: October 31, 2026

Triethylamine → HCID 56846742, compound

https://huagongshe.com/reaction/2369368

Reaction equation

Participants

RoleNameHCIDCharge
ReactantTriethylamineHCID 8471—
ReactantEthyl chloroformateHCID 10928—
Reactant1-HydroxybenzotriazoleHCID 75771—
Reactant4-Amino-5-chloro-2-methoxybenzoic acidHCID 81626—
ReactantHCID 66611481HCID 66611481—
SolventDimethylformamideHCID 6228—
ProductHCID 56846742HCID 5684674271%

Reaction Steps

In a dry 50 mL flask, 0.44 g (2.2 mmol; 1.1 equiv) of 4-amino-5-chloro-2-methoxybenzoic acid and 0.30 g (3 mmol; 1.5 equiv) of triethylamine were dissolved in 25 mL of dimethylformamide and stirred during 10 minutes at room temperature. Then the mixture was cooled to 0° C. and 0.24 g (2.2 mmol; 1.1 equiv) of ethyl chloroformate was added and stirred during 30 minutes at room temperature. Then 0.29 g (2.2 mmol; 1.1 equiv) of 1-hydroxybenzotriazole was added and stirred during 30 minutes at room temperature. Then 0.57 g of 3,3-difluoro-1-[3-(4-fluorophenoxy)propyl]piperidin-4-amine 16 was added and the mixture was stirred at room temperature during 15 hours. After evaporation of the solvent in vacuo, the crude oil was redissolved in EtOAc and poured in 50 mL of brine and extracted with EtOAc (4×50 mL). The organic phases were washed with brine and dried over MgSO4. After filtration of the solids and evaporation of the solvent under vacuum, the crude oil was purified via flash chromatography (hexane/EtOAc 3:7, Rf=0.35) yielding 0.66 g (1.4 mmol; 71% yield) of pure 4-amino-5-chloro-N-{3,3-difluoro-1-[3-(4-fluorophenoxy)propyl]piperidin-4-yl}-2-methoxybenzamide 17 as white crystals. M.p.=125.8° C. (hexane/EtOH 1:1). 1H NMR (CDCl3): δ 1.70 (1H, ddd, J=24.8 Hz, 12.7 Hz, 3.9 Hz, CHaHb); 1.93 (2H, quintet, J=6.6 Hz, CH2); 2.01-2.12 (1H, m, CHaHb); 2.21 (1H, t, J=11.8 Hz, NCHaHb); 2.34 (1H, ddd, J=28.8 Hz, 11.3 Hz, 1.7 Hz, NCHaHbCF2); 2.50-2.69 (2H, m, NCH2); 2.92 (1H, d, J=11.8 Hz, NCHaHb); 3.19 (1H, td, J=11.3 Hz, 4.4 Hz, NCHaHbCF2); 3.86 (3H, s, OCH3); 3.96 (2H, t, J=6.6 Hz, OCH2); 4.43 (3H, s(broad), NCH and NH2); 6.26 (1H, s, CHar); 6.81 (2H, dd, J=8.8 Hz, 4.4 Hz, 2×CHar); 6.94 (2H, t, J=8.8 Hz, 2×CHar); 8.03 (1H, s(broad), NH); 8.06 (1H, s, CHar). 19F NMR (CDCl3): δ −107.6 (1F, d, J=240.7 Hz, CFaFb); −116.9 (1F, d(broad), J=240.7 Hz, CFaFb); −124.0 (1F, tt, J=7.9 Hz, 4.0 Hz, CarF). 13C NMR (CDCl3): δ 26.8 (CH2, alkyl); 29.6 (d, J=5.8 Hz, CH2); 50.2 (t, J=19.6 Hz, NCH); 51.5 (NCH2); 53.9 (NCH2, alkyl); 56.2 (OCH3); 58.0 (dd, J=29.4 Hz, 23.7 Hz, NCH2CF2); 66.3 (OCH2); 97.8 (CHar); 111.6 (CarCO); 111.9 (CarCl); 115.4 (d, J=8.1 Hz, 2×CHar); 115.7 (d, J=23.1 Hz, 2×CHar); 118.9 (t, J=245.8 Hz, CF2); 133.1 (CHar); 147.1 (CarNH2); 155.0 (d, J=2.3 Hz, OCar); 157.2 (d, J=237.7 Hz, CarF); 157.6 (CarOMe); 164.4 (C═O). IR (ATR, cm−1): ν=3480; 3398; 3329; 3194; 2964; 2886; 2818; 1641; 1614; 1584; 1538; 1506; 1462; 1318; 1247; 1208; 1146; 1124; 1074; 1037; 982; 910; 822; 753; 681. MS (ES+) m/z (%): 472/474 (M+H+, 100).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08703958B2
Source datasetuspto-grants-2014_04
ORD IDord-16b2d7f2776b4bfc91a0fed94c3ea454
Source noteuspto-grants-2014_04